References
- Jennette JC, Falk RJ, Bacon PA, et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.
- Comarmond C, Pagnoux C, Khellaf M, et al; for the French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65:270–281.
- Trivioli G, Terrier B, Vaglio A. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford). 2020;59:iii84–iii94.
- Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65–81.
- Lega JC, Seror R, Fassier T, et al; French Vasculitis Study Group (FVSG). Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter study. Semin Arthritis Rheum. 2014;43:681–688.
- Otani Y, Anzai S, Shibuya H, et al. Churg-Strauss syndrome (CSS) manifested as necrosis of fingers and toes and liver infarction. J Dermatol. 2003;30:810–815.
- Inui S, Itami S, Iwai C, et al. Churg-Strauss syndrome involving medium-sized arteries. J Dermatol. 2001;28:161–164.
- Braunberger T, Mounessa JS, O'Leary R, et al. Limb-threatening arterial thrombosis in a patient with eosinophilic granulomatosis with polyangiitis. J Am Coll Clin Wound Spec. 2016;8:28–30.
- Zekić T. Cardiac involvement in eosinophilic granulomatosis with polyangiitis. Rheumatol Int. 2018;38:705–706.
- Guillevin L, Pagnoux C, Seror R, et al. The Five-Factor Score revisited assessment of prognoses of systemic necrotizing vasculitides based on French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90:19–27.
- Moosig F, Bremer JP, Hellmich JU, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis. 2013;72:1011–1017.
- Samson M, Puechal X, Devilliers H, et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. J Autoimmun. 2013;43:60–69.
- Cottin V, Bel E, Bottero P, et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaries and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev. 2017;16:1–9.
- Drogue M, Vergnon JM, Wintzer B, et al. Prinzmetal’s angina pectoris revealing aneurysm of the right coronary artery during evolution of Churg-Strauss syndrome. Chest. 1993;103:978.
- Hartmann M, Wajon EM, van Houwelingen GK, et al. Giant coronary aneurysm in Churg-Strauss syndrome. EuroIntervention. 2012;8:760–761.
- Htun P, Horger M, Gawaz M, et al. Giant coronary artery aneurysms and eosinophilic granulomatosis with polyangiitis. Arthritis Rheum. 2013;65:1406.
- Doo KW, Yong HS, Kang EY. Coronary involvement in Churg-Strauss syndrome: a case report with CT findings. Jpn J Radiol. 2013;31:819–822.
- Riksen NP, Gehlmann H, Brouwer AE, et al. Complete remission of coronary vasculitis in Churg-Strauss Syndrome by prednisone and cyclophosphamide. Clin Rheumatol. 2013;32:41–42.
- Kido K, Tokuda R, Suzuki T, et al. Anesthetic management for surgery of giant coronary aneurysms complicated with Churg-Strauss syndrome. Masui. 2014;63:451–455.
- Cho Y, Choe H, Kang BR, et al. Development of a coronary aneurysm at a sirolimus-eluting stent-implanted lesion in a patient with churg-strauss syndrome. Korean Circ J. 2011;41:559–562.
- Allanore Y, Denton CP, Krieg T, DUO Investigators, et al. Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort. Ann Rheum Dis. 2016;75:1736–1740.
- Asherson RA, Frances C, Iaccarino L, et al. The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy. Clin Exp Rheumatol. 2006;24:S46–S51.
- Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001;357:2042–2048.
- Bertolazzi C, Gallegos-Nava S, Villarreal-Trevino AV, et al. The current role of capillaroscopy in vasculitides. Clin Rheumatol. 2019;38:2299–2307.
- Richard W, Suzanne L, Thomas H, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rhem Dis. 2007;66:222–227.
- Tezuka D, Haraguchi G, Inagaki H, et al. Progression of thrombogenesis in large coronary aneurysms during anticoagulant therapy in a Buerger’s disease patient. BMJ Case Rep. 2013;2013:bcr2013009945.
- Abe M, Kimura T, Furukawa Y, et al. Coronary Buerger’s disease with a peripheral arterial aneurysm. Eur Heart J. 2007;28:928.